Fayez Sarofim & CO Idexx Laboratories Inc Transaction History

Fayez Sarofim & CO

$38.7 Billion
Q3 2024

A detailed history of Fayez Sarofim & CO transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Fayez Sarofim & CO holds 2,629 shares of IDXX stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,629

Previous 2,629 -0.0%

Holding current value

$1.14 Million

Previous $1.28 Million 3.67%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$468.04 - $548.53 $93,608 - $109,706	200 Added 8.23%	2,629 $1.28 Million
Q1 2024 May 14, 2024	BUY	$515.08 - $576.87 $103,016 - $115,374	200 Added 8.97%	2,429 $1.31 Million
Q4 2023 Feb 14, 2024	BUY	$391.37 - $557.56 $254,390 - $362,413	650 Added 41.17%	2,229 $1.24 Million
Q3 2023 Nov 14, 2023	SELL	$432.42 - $556.67 $43,242 - $55,666	-100 Reduced 5.96%	1,579 $690,000
Q1 2023 May 11, 2023	SELL	$406.01 - $514.59 $45,473 - $57,634	-112 Reduced 6.25%	1,679 $839,000
Q3 2022 Nov 14, 2022	BUY	$325.8 - $407.78 $57,015 - $71,361	175 Added 10.83%	1,791 $584,000
Q2 2022 Aug 12, 2022	SELL	$327.37 - $553.44 $45,177 - $76,374	-138 Reduced 7.87%	1,616 $567,000
Q3 2020 Nov 13, 2020	SELL	$334.54 - $406.31 $62,893 - $76,386	-188 Reduced 9.68%	1,754 $690,000
Q1 2020 May 12, 2020	SELL	$182.94 - $290.97 $18,294 - $29,097	-100 Reduced 4.9%	1,942 $470,000
Q4 2019 Feb 14, 2020	BUY	$248.66 - $285.01 $24,866 - $28,501	100 Added 5.15%	2,042 $533,000
Q4 2018 Feb 13, 2019	BUY	$176.18 - $248.92 $132,839 - $187,685	754 Added 63.47%	1,942 $361,000
Q2 2018 Aug 14, 2018	SELL	$185.56 - $227.9 $61,605 - $75,662	-332 Reduced 21.84%	1,188 $259,000
Q3 2017 Nov 08, 2017	BUY	$150.32 - $166.46 $228,486 - $253,019	1,520	1,520 $236,000

Others Institutions Holding IDXX

# of Institutions

1,191

Shares Held

72.6M

Call Options Held

167K

Put Options Held

343K

View Full List

About IDEXX LABORATORIES INC

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $36.2B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

More about IDXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fayez Sarofim & CO, based on Form 13F filings with the SEC.

News

Stay updated on Fayez Sarofim & CO with notifications on news.

Account